| Typicality: | 0.317 |
| Saliency: | 0.157 |
| in participants | 3 | other |
| trial → test → the vaccine’s safety | 5 |
| trial → examine → the vaccine’s safety | 3 |
| negative | neutral | positive |
| 0.082 | 0.841 | 0.077 |
| Raw frequency | 8 |
| Normalized frequency | 0.157 |
| Modifier score | 0.500 |
| Perplexity | 206.751 |